Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2007 Feb 15;17(4):1056-61. Epub 2006 Nov 15.

Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups--new classes of PPAR gamma/delta and PPAR alpha/gamma/delta agonists.

Author information

1
Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA. david.cantin.b@bayer.com

Abstract

Modulation of PPAR activities represents an attractive approach for the treatment of diabetes with associated cardiovascular complications. The indanylacetic acid structural motif has proven useful in the generation of potent and tunable PPAR ligands. Modification of the substituents on the linker and the heterocycle tail group allowed for the modulation of the selectivity at the different receptor subtypes. Compound 33 was evaluated in vivo, where it displayed the desired reduction of glucose levels and increase in HDL levels in various animal models.

PMID:
17157013
DOI:
10.1016/j.bmcl.2006.11.025
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center